Dutch Shift Approach to Funding

AMSTERDAM—The Dutch government is moving toward a system of funding large research institutions by supporting a limited number of broadly defined goals rather than by issuing grants to thousands of individual investigators. The change is expected to give the institutions greater independence to allocate funds and make the process more responsive both to the needs of the scientific community and to national priorities. The current system encourages conflict between scientists and government

Written byMalik De Kok
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The current system encourages conflict between scientists and government bureaucrats over individual allocations, said E. van Spiegel, director-general of the Division of Science Policy in the Ministry of Education and Science.

"The civil servant has the opportunity—often the duty—to occupy himself with details," said Spiegel. "Travel expenses, for example, may be an insignificant part of the total budget. But they can cause enormous fights within an organization about whether each professor has been given his proper share."

Under the new system, the government sets broad goals and leaves to the institution the task of developing strategies to meet these goals. Organizations will be free to decide how to disburse their funds among additional staff, new equipment, improvements in their physical plant, or to meet other needs. The practice of buying equipment in December with funds remaining in an expiring budget will become a thing of the past, Spiegel said.

In ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies